|Articles|November 1, 2005

Pharmacy Times

  • Volume 0
  • 0

Probiotics Alleviate IBS Symptoms

The etiology of irritable bowel syndrome(IBS) has not been fully defined, and theeffects of probiotics on this gastrointestinal(GI) motility disorder remain unclear. KajsaKajander, MSc, and colleagues conducteda randomized, double-blind, placebo-controlledtrial to investigate the effects of aprobiotic mixture containing Lactobacillusrhamnosus GG, L rhamnosus LC705, Bifidobacteriumbreve Bb99, and Propionibacteriumfreudenreichii subsp shermanii JSon IBS symptoms.

Patients meeting Rome I or Rome II criteriafor IBS (n = 103) were treated with aprobiotic capsule or a placebo daily for 6months. GI symptoms and bowel habitswere recorded.

At the end of the study, the medianreduction in symptom score (abdominalpain + distension + flatulence + borborygmi)was 42% in the probiotic group, comparedwith 6% in the placebo group (P =.015). For individual symptoms, borborygmiwas milder in the probiotic group (P =.008), but no significant trends wereobserved for other individual symptoms.These results suggested that this probioticmixture is effective in alleviating symptomsassociated with IBS (Alimentary Pharmacologyand Therapeutics, September 2005).

Articles in this issue

about 20 years ago

COMPOUNDING HOTLINE

about 20 years ago

Compounding: Treating Mouth Ulcers

about 20 years ago

CAN YOU READTHESE Rxs?

about 20 years ago

RxWise

about 20 years ago

AutoBox

about 20 years ago

LucidLinkWireless Security

about 20 years ago

MILT 2.0

about 20 years ago

PACMED

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME